Hybridoma technology: is it still useful?

The isolation of single monoclonal antibodies (mAbs) against a given antigen was only possible with the introduction of the hybridoma technology, which is based on the fusion of specific B lymphocytes with myeloma cells. Since then, several mAbs were described for therapeutic, diagnostic, and resear...

Descripción completa

Detalles Bibliográficos
Autores principales: Moraes, Jane Zveiter, Hamaguchi, Bárbara, Braggion, Camila, Speciale, Enzo Reina, Cesar, Fernanda Beatriz Viana, Soares, Gabriela de Fátima da Silva, Osaki, Juliana Harumi, Pereira, Tauane Mathias, Aguiar, Rodrigo Barbosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040095/
https://www.ncbi.nlm.nih.gov/pubmed/35492397
http://dx.doi.org/10.1016/j.crimmu.2021.03.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040095/
https://www.ncbi.nlm.nih.gov/pubmed/35492397
http://dx.doi.org/10.1016/j.crimmu.2021.03.002

Ejemplares similares